Outcomes for haploidentical transplantation have improved significantly over the past decade. Advances in conditioning regimens, GVHD prophylaxis, and supportive care have led to survival rates that are comparable to those of matched unrelated donor transplants. Success rates vary depending on the underlying condition being treated, the patient's overall health, and other factors.
